Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier, and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins believes it is a global leader in food, environmental, pharmaceutical and cosmetics products testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies.
In over just 30 years, Eurofins has grown from one laboratory in Nantes, France to over 62,000 staff across a network of more than 1000 independent companies in over 62 countries and operating more than 900 laboratories. Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. In 2025, Eurofins generated total revenues of EUR € 7.296 billion and has been among the best performing stocks in Europe over the past 20 years.
Eurofins BioPharma Product Testing Australia / New Zealand provides contract GMP testing to human and animal pharmaceutical, biotechnology, medical device, and complimentary medicine manufactures, as well as an extensive range of SPF and other cosmetics testing, both in-vitro and in-vivo in accordance with a range of local and international standards. The range of testing includes microbiological and chemistry on raw materials, in process and finished products, complemented by product formulation services. We operate out of sites in Sydney, Melbourne, and Auckland, which are all GMP licensed by local regulators and are accredited to ISO 17025. In addition to the provision of world class analytical testing, the laboratories also provide consultative services to their clients made available by a team of highly qualified scientists.
We are seeking Analytical Service Officer (ASO) to join us on a casual basis from June 2026 .
The Analytical Service Officer is responsible for client liaising for sample receipt, discrepancies, daily scheduling of the analytical service and registration teams and all related processes. The Analytical Service Officer will also ensure efficient day to day operations of the analytical service and registration teams, including daily allocation of duties, meeting agreed turnaround times (TAT), and will have direct participation in meeting quality and efficiency standards and meeting objectives as directed by Analytical Service Manager and the Business Unit Manager.
Responsibilities for this role include but are not limited to:
About you:
This opportunity is only open to candidates who are eligible to work in Australia/New Zealand, and already have work rights or an appropriate working visa.
If you feel that you can bring outstanding skills and a great attitude to our team, please submit a cover letter, curriculum vitae and be able to provide at least two recent professional references. Applications will be treated with the strictest confidence. Due to the volume of responses we may only contact shortlisted candidates.
Please note: Current Eurofins employees should first speak with their Business Unit Manager before submitting an application for this position.

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories.
Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.
Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.